Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes-Reference-Cited by-同舟云学术

Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes

Published:2009-05 Issue:5 Volume:37 Page:616-628.e2
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Franceschetti Marta,Pievani Alice,Borleri Gianmaria,Vago Luca,Fleischhauer Katharina,Golay Josée,Introna Martino

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference52 articles.

1. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency;Lu;J Immunol,1994

2. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice;Hoyle;Blood,1998

3. Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation;Alvarnas;Biol Blood Marrow Transplant,2001

4. Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts;Linn;Br J Haematol,2002

5. Expansion of CD3+CD56+ cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy;Lefterova;Haematologica,2000

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can Cytokine-induced killer cells overcome CAR-T cell limits;Frontiers in Immunology;2023-08-22

2. Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review;Experimental Hematology & Oncology;2023-08-21

3. Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing;BMC Immunology;2023-06-29

4. Manufacturing and Treatment Standardization of Tumor Associated Antigen Stimulated Autologous Dendritic and Cytokine Induced Killer Cell Coculture for Cancer Immunotherapy;2023-02-24

5. Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma;PLOS ONE;2023-01-04